Trade LKFT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Lakefront Biotherapeutics American Depositary Shares (LKFT) is trading at US$28.55, down 1.25% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$1.89B. Over the past 52 weeks, LKFT has traded between US$25.68 and US$37.78. On Syfe you can trade LKFT with $0 commission and add it to your watchlist.
| Previous close | US$28.91 |
|---|---|
| Market cap | US$1.89B |
| 52-week range | US$25.68 – US$37.78 |
| Volume | 459.09K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Lakefront Biotherapeutics American Depositary Shares
Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Year: 2008
--RBC Adjusts PT on Lakefront Biotherapeutics to $26 From $28, Keeps Sector Perform Rating
Aug 11, 10:53 AM · MT Newswires
Morgan Stanley Adjusts PT on Lakefront Biotherapeutics to $26 From $30, Maintains Equalweight Rating
Aug 11, 9:31 AM · MT Newswires
Lakefront Biotherapeutics Launches 50 Million Euros Share Repurchase Program
Jun 9, 8:18 PM · MT Newswires
Lakefront Biotherapeutics Names Eric Hedrick as Chief Medical Officer
Jun 8, 8:19 PM · MT Newswires
Stay on top of LKFT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
